![N-Cyclohexyl-4-[1-(1-piperazinyl)-2, 6-naphthyridin-3-yl]-2-pyridinamine](https://cdn11.bigcommerce.com/s-2kvb5rm600/images/stencil/600x600/products/47114/43770/TargetMol-768x384__12443.1665998863__74673.1666031459.png?c=1 "N-Cyclohexyl-4-[1-(1-piperazinyl)-2, 6-naphthyridin-3-yl]-2-pyridinamine")
![N-Cyclohexyl-4-[1-(1-piperazinyl)-2, 6-naphthyridin-3-yl]-2-pyridinamine](https://cdn11.bigcommerce.com/s-2kvb5rm600/images/stencil/1280x1280/products/47114/43770/TargetMol-768x384__12443.1665998863__74673.1666031459.png?c=1 "N-Cyclohexyl-4-[1-(1-piperazinyl)-2, 6-naphthyridin-3-yl]-2-pyridinamine")
Product Overview
N-Cyclohexyl-4-[1-(1-piperazinyl)-2, 6-naphthyridin-3-yl]-2-pyridinamine | T9256 | TargetMol Chemicals
CAS: 1071135-06-2
Smiles:
Formula: N/A
Pathway: Cell Cycle/Checkpoint|||Chromatin/Epigenetic|||Cytoskeletal Signaling|||Metabolism
Target: Serine/threonin kinase|||PKC
Receptor: N/A
Bioactivity: N-Cyclohexyl-4-[1-(1-piperazinyl)-2, 6-naphthyridin-3-yl]-2-pyridinamine is a novel 2, 6-naphthyridine identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor[1].
Molecular Weight: N/A
![N-((4-([1, 2, 4]triazolo[1, 5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline](https://cdn11.bigcommerce.com/s-2kvb5rm600/images/stencil/500x659/products/47516/44172/TargetMol-768x384__12443.1665998863__91005.1666031932.png?c=1 "N-((4-([1, 2, 4]triazolo[1, 5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline")
